Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1CNS 1

Conditions

Sarcoma, Ewing 1Rhabdomyosarcoma 1Osteosarcoma 1Neuroblastoma 1Medulloblastoma 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1Ependymoma 1Craniopharyngioma 1

Interventions

Nivolumab 10Doxorubicin 10Cyclophosphamide 10Vinblastine 9Radiotherapy 8Dacarbazine 8Brentuximab Vedotin 8Bleomycin 7fludarabine phosphate 6fludarabine 6Prednisone 6Etoposide 6pembrolizumab 5Melphalan 5Whole-Body Irradiation 4Vincristine 4Mycophenolic Acid 4Filgrastim 4Tacrolimus 3Radiation 3Prednisolone 3Peripheral Blood Stem Cell Transplantation 3Granulocyte Colony-Stimulating Factor 3Busulfan 3Thiotepa 2Sirolimus 2Procarbazine 2Mechlorethamine 2Bendamustine Hydrochloride 2tislelizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Hodgkin Disease × Methionine × Clear all
NCT00840047 2026-04-24

Methionine PET/CT Studies In Patients With Cancer

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
503 enrolled
CNSLymphoidSarcoma

Craniopharyngioma, Ependymoma, Hodgkin Disease, Lymphoma, Non-Hodgkin, Medulloblastoma, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡